# Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers

> **NCT02389192** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ZMAPP

## Key facts

- **NCT ID:** NCT02389192
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03-11
- **Primary completion:** 2017-12-27
- **Final completion:** 2017-12-27
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389192, "Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02389192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*